American Regent, Inc.
Clinical trials sponsored by American Regent, Inc., explained in plain language.
-
Experimental drug shows promise for rare eye cancer
Disease control CompletedThis study tested a drug called Taxoprexin in 22 people with advanced eye melanoma that had spread to other parts of the body. The goal was to see if the drug could shrink tumors and how safe it was. Participants received weekly injections, and researchers measured tumor response…
Phase: PHASE2 • Sponsor: American Regent, Inc. • Aim: Disease control
Last updated May 17, 2026 02:05 UTC
-
New drug shows promise in advanced skin cancer trial
Disease control CompletedThis study tested a weekly chemotherapy drug called Taxoprexin in 30 people with advanced melanoma that had spread to other parts of the body. The goal was to see if the drug could shrink tumors and how long that effect might last. Participants had not received chemotherapy befor…
Phase: PHASE2 • Sponsor: American Regent, Inc. • Aim: Disease control
Last updated May 15, 2026 11:54 UTC